Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Rhea-AI Summary

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) announced their participation in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference. The management team will hold a fireside chat on February 8, 2024, to discuss the company's focus on discovering, developing, and commercializing new medicines for cancer patients. The event will be live webcasted and available for replay on the company's website.

WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6^th Annual Biotechnology Conference on Thursday, February 8, 2024 at 9:00 AM ET in New York, NY.

A live webcast of the fireside chat will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Iceland, Israel, Liechtenstein, Macau, New Zealand, Norway, Singapore, Switzerland, Taiwan, The United Kingdom, and the United States. For more information, visit www.deciphera.com and follow us on LinkedIn and X (@Deciphera).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240201922448/en/

Investor Relations:

Maghan Meyers

Argot Partners

Deciphera@argotpartners.com

212-600-1902

Media:

David Rosen

Argot Partners

david.rosen@argotpartners.com

212-600-1902

Source: Deciphera Pharmaceuticals, Inc.

FAQ

What is the ticker symbol for Deciphera Pharmaceuticals, Inc.?

The ticker symbol for Deciphera Pharmaceuticals, Inc. is DCPH.

When will the fireside chat take place at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference?

The fireside chat will take place on February 8, 2024, at 9:00 AM ET.

Where can I watch the live webcast of the fireside chat?

The live webcast will be available on the 'Events and Presentations' page in the 'Investors' section of the Company’s website at https://investors.deciphera.com/events-presentations.

How long will the replay of the webcast be available on the company's website?

The replay of the webcast will be archived on the Company’s website for 90 days following the presentation.